A Study of Zetomipzomib (KZR-616) in Patients With Active Lupus Nephritis (PALIZADE) (clinicaltrials.gov) - Jun 7, 2023 - P2b | N=279 | Recruiting | Sponsor: Kezar Life Sciences, Inc. | Not yet recruiting ➔ Recruiting
Enrollment open • Glomerulonephritis • Immunology • Inflammatory Arthritis • Lupus • Lupus Nephritis • Nephrology
|